Patents by Inventor Deborah Duffey

Deborah Duffey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
    Publication number: 20210401766
    Abstract: A method of administering a composition having Cannabis sativa-derived substances nano-encapsulated in phospholipid vesicles for transmucosal and transdermal delivery is disclosed. A Cannabis sativa-derived formulation for transmucosal and transdermal delivery comprising Cannabis sativa-derived compounds nanoencapsulated in phospholipid-based vesicles is also disclosed. Cannabis sativa-derived extracts have enhanced bioavailability when encapsulated in nanosized phospholipid vesicles prior to administration to a subject as compared to non-encapsulated cannabinoids.
    Type: Application
    Filed: September 21, 2021
    Publication date: December 30, 2021
    Applicant: NuVessl, Inc.
    Inventors: Tanya Rhodes, Deborah Duffey
  • Method of encapsulating cannabinoids in phospholipid carriers
    Patent number: 11020355
    Abstract: A method of encapsulating cannabis-derived compounds in nanosized phospholipid vesicles is disclosed. A Cannabis sativa-derived formulation for transmucosal and transdermal delivery comprising Cannabis sativa-derived compounds nanoencapsulated in phospholipid-based vesicles is also disclosed. Cannabis sativa-derived extracts have enhanced bioavailability when encapsulated in nanosized phospholipid vesicles prior to administration to a subject as compared to non-encapsulated cannabinoids. Also disclosed herein are methods of transmucosal and transdermal administration of the formulation having phospholipid vesicles with nanoencapsulated Cannabis sativa-derived substances.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: June 1, 2021
    Assignee: NuVessl, Inc.
    Inventors: Tanya Rhodes, Deborah Duffey
  • Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
    Publication number: 20200078316
    Abstract: A method of administering a composition having Cannabis sativa-derived substances nano-encapsulated in phospholipid vesicles for transmucosal and transdermal delivery is disclosed. A Cannabis sativa-derived formulation for transmucosal and transdermal delivery comprising Cannabis sativa-derived compounds nanoencapsulated in phospholipid-based vesicles is also disclosed. Cannabis sativa-derived extracts have enhanced bioavailability when encapsulated in nanosized phospholipid vesicles prior to administration to a subject as compared to non-encapsulated cannabinoids.
    Type: Application
    Filed: September 4, 2019
    Publication date: March 12, 2020
    Applicant: NuVessl, Inc.
    Inventors: Tanya Rhodes, Deborah Duffey
  • Method of Encapsulating Cannabinoids in Phospholipid Carriers
    Publication number: 20200078297
    Abstract: A method of encapsulating cannabis-derived compounds in nanosized phospholipid vesicles is disclosed. A Cannabis sativa-derived formulation for transmucosal and transdermal delivery comprising Cannabis sativa-derived compounds nanoencapsulated in phospholipid-based vesicles is also disclosed. Cannabis sativa-derived extracts have enhanced bioavailability when encapsulated in nanosized phospholipid vesicles prior to administration to a subject as compared to non-encapsulated cannabinoids. Also disclosed herein are methods of transmucosal and transdermal administration of the formulation having phospholipid vesicles with nanoencapsulated Cannabis sativa-derived substances.
    Type: Application
    Filed: September 4, 2019
    Publication date: March 12, 2020
    Applicant: NuVessl, Inc.
    Inventors: Tanya Rhodes, Deborah Duffey
  • Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery
    Publication number: 20200078427
    Abstract: A Cannabis sativa-derived formulation for transmucosal and transdermal delivery is disclosed comprising Cannabis sativa-derived compounds nanoencapsulated in phospholipid-based vesicles. A method of encapsulating cannabis-derived compounds in nanosized phospholipid vesicles is also disclosed. Cannabis sativa-derived extracts have enhanced bioavailability when encapsulated in nanosized phospholipid vesicles prior to administration to a subject as compared to non-encapsulated cannabinoids. Also disclosed herein are methods of transmucosal and transdermal administration of the formulation having phospholipid vesicles with nanoencapsulated Cannabis sativa-derived substances.
    Type: Application
    Filed: September 4, 2019
    Publication date: March 12, 2020
    Applicant: NuVessl, Inc.
    Inventors: Tanya Rhodes, Deborah Duffey
  • Headliner assembly and locating method
    Patent number: 5795015
    Abstract: An automotive vehicle body and headliner assembly and locating method. The headliner has two locating holes. The body includes a pair of bodyside assemblies each with a door opening having a peripheral flange, a pair of A-pillar assemblies each having a reinforcement with a visor hole, and a roof assembly including a roof outer panel and front and rear roof headers longitudinally spaced along the roof outer panel. The A-pillar assemblies and bodyside assemblies are secured to the roof assembly. Locators are provided on the body for locating the headliner with respect to the body. The locators are located laterally on the body relative to one of the bodyside assemblies. The locators are alignable with the locating holes in the headliner.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: August 18, 1998
    Assignee: Ford Global Technologies, Inc.
    Inventors: Edward J. Corpe, Deborah Duffey, Jeffrey D. Elliott